Drug Trial Radar · NCT05238025
MVA-BN-RSV Vaccine Trial
Last checked: Nov 19, 2026Latest source record: Oct 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20,419
Actual
Start
Apr 19, 2022
Primary completion
Jun 29, 2023
Study completion Sep 1, 2023
Sponsor
- Lead sponsor
- Bavarian NordicIndustry
- Sponsor type
- Industry
- First posted
- Feb 14, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Phase 3 randomized, double blind study comparing recombinant MVA-BN-RSV vaccine vs placebo for efficacy and safety in adults \>=60 years of age
Conditions
- Respiratory Syncytial Virus Infections
Interventions
MVA-BN-RSV vaccineBiological
One injection, suspension for injection, intramuscular use, 0.5mL MVA-BN-RSV virus with a titer of at least 3 x 10E8 infectious units (Inf.U)/0.5mL in a Tris buffer at pH 7.7.
Tris Buffered Saline (TBS)Biological
One injection, solution for injection, intramuscular use, 0.5mL TBS, pH 7.7.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of PCR Confirmed RSV-associated LRTD With at Least 3 SymptomsTime frame: From 14 days post-vaccination up to the end of one RSV season, up to a maximum of 11 months
- Occurrence of PCR Confirmed RSV-associated LRTD With at Least 2 SymptomsTime frame: From 14 days post-vaccination up to the end of one RSV season, up to a maximum of 11 months
Locations
120 sites in 2 countries. Site status is shown where the registry gives one.
North Alabama Research Center, LLC
Athens, Alabama
Central Alabama Research
Birmingham, Alabama
Achieve Clinical Research, LLC d/b/a Accel Research Sites
Birmingham, Alabama
Medical Affiliation Research Center
Huntsville, Alabama
Lenzmeier Family Medicine / CCT Research
Glendale, Arizona
Aventiv Research Inc.
Mesa, Arizona
Phoenix Clinical LLC
Phoenix, Arizona
Pain Center of Arizona
Phoenix, Arizona
Cognitive Clinical Trials, LLC
Phoenix, Arizona
Fiel Family and Sports Medicine/CCT Research
Tempe, Arizona
HOPE Research Institute
Tempe, Arizona
Tucson Neuroscience Research, LLC
Tucson, Arizona
Lynn Institute of the Ozarks
Little Rock, Arkansas
Hope Clinical Research, LLC
Canoga Park, California
Marvel Clinical Research 002, LLC
Huntington Beach, California
Join Clinical Trials
Huntington Park, California
Paradigm Clinical Research Center
La Mesa, California
Atella Clinical Research LLC
La Palma, California
Chemidox Clinical Trials Inc.
Lancaster, California
ARK Clinical Research
Long Beach, California
Matrix Clinical Research
Los Angeles, California
Artemis Institute for Clinical Research
San Diego, California
California Research Foundation
San Diego, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Lynn Institute of Denver
Aurora, Colorado
Innovative Research Of West Florida, Inc.
Clearwater, Florida
Doral Medical Research
Hialeah, Florida
K2 Medical Research, LLC
Maitland, Florida
Optimus U Corporation
Miami, Florida
De La Cruz Research Center, LLC
Miami, Florida
Global Health Research Center, Inc
Miami Lakes, Florida
Pines Care Research Center, LLC
Pembroke Pines, Florida
IDEAL Clinical Research
Pembroke Pines, Florida
Centricity Research Columbus Multispecialty
Columbus, Georgia
Accel Research Site - Neurostudies
Decatur, Georgia
Lifeline Primary Care/CCT Research
Lilburn, Georgia
Meridian Clinical Research, LLC
Savannah, Georgia
Bingham Memorial Hospital
Blackfoot, Idaho
Clinical Research Prime
Idaho Falls, Idaho
Snake River Research, PLLC
Idaho Falls, Idaho
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.